Am J Gastroenterol

1. OCHOA-ALLEMANT P, Kiran A, Mezzacappa C, Kaplan DE, et al
   Steatotic Liver Disease Has Surpassed Viral Hepatitis as the Leading Cause of Cirrhosis in the U.S. Veterans Health System.
   Am J Gastroenterol. 2026 Feb 18. doi: 10.14309/ajg.0000000000003966.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

2. XU J, Yang H, Wei H, Li H, et al
   Atractylon induces autophagy-dependent apoptosis in hepatocellular carcinoma cells via inhibition of the PI3K/AKT/mTOR pathway.
   Biochem Biophys Res Commun. 2026;808:153465.
   

   >> Share

   
   
3. FUJIWARA N, Mitsui I, Tsunedomi R, Hayakawa K, et al
   Protein phosphatase 6 protects hepatocytes from endoplasmic reticulum and oxidative stress by suppressing Akt/mTOR signaling.
   Biochem Biophys Res Commun. 2026;808:153463.
   

   >> Share

   
   

   
   BMC Cancer

4. LIU X, Wang Z, Lv X, Wang J, et al
   Immune effect of Traditional Chinese Medicine combined with transcatheter arterial chemoembolization in treatment of liver cancer: a meta-analysis.
   BMC Cancer. 2026;26:263.
   

   >> Share

   
   
5. YANG Z, Li T, Shen J, Huang Y, et al
   Multi-omics SMR and experimental supportive analyses decipher causal drivers hepatocellular carcinoma.
   BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15667.
   

   >> Share

   
   

   
   BMC Gastroenterol

6. ZHONG HY, Ma LD, Li JC, Jiang D, et al
   Associations of relative fat mass with metabolic dysfunction-associated steatotic liver disease and liver fibrosis: evidence from the U.S. NHANES 2017-2023.
   BMC Gastroenterol. 2026;26:139.
   

   >> Share

   
   
7. LIU Y, Zhang Q, Li J, Wu X, et al
   mNGS improves the efficiency of infection diagnosis and treatment in acute-on-chronic liver failure.
   BMC Gastroenterol. 2026;26:129.
   

   >> Share

   
   

   
   Dig Dis Sci

8. ZHANG Q, Liu P, Xu X, Yang Y, et al
   Clinical Outcomes of Acute Pancreatitis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis.
   Dig Dis Sci. 2025 Aug 14. doi: 10.1007/s10620-025-09300.
   

   >> Share

   
   

   
   Endoscopy

9. NAMIMA D, Kamada H, Shimizu Y, Fujita N, et al
   Handmade snare technique for grasping and repositioning biliary stents via the endoscopic ultrasound-guided hepaticojejunostomy route.
   Endoscopy. 2026;58.
   

   >> Share

   
   
10. HARA A, Minaga K, Otsuka Y, Takenaka M, et al
    Rescue multihole metal stent placement to prevent stent migration after endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2026;58.
    

    >> Share

    
    
11. MARUYAMA H, Ishikawa-Kakiya Y, Kawata Y, Kurokawa T, et al
    Troubleshooting: intraperitoneal migration of a dedicated plastic stent during endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2026;58.
    

    >> Share

    
    

    
    Eur Radiol

12. ZHOU J, Ouyang S, Chen H, Zhang D, et al
    The value of LI-RADS ancillary features and biomarker for hepatocellular carcinoma
    Eur Radiol. 2026 Feb 20. doi: 10.1007/s00330-026-12381.
    

    >> Share

    
    

    
    Gastrointest Endosc

13. RANA SS, Mewara A, Acharya R, Reddysetti S, et al
    Cholangioscopic Diagnosis of Intrahepatic Fascioliasis Presenting as Eosinophilic Ascites in a Non-Endemic Area.
    Gastrointest Endosc. 2026 Feb 17:S0016-5107(26)00116.
    

    >> Share

    
    

    
    Gut

14. BHANUSHALI M, Bhagat N, De A, Duseja A, et al
    Metabolic determinants of hepatocellular carcinoma after SVR: persisting uncertainties.
    Gut. 2026 Feb 20:gutjnl-2026-338377. doi: 10.1136/gutjnl-2026-338377.
    

    >> Share

    
    

    
    Hepatology

15. MA X, Niu M, Ni HM, Ding WX, et al
    Mitochondrial dynamics, quality control, and mtDNA in alcohol-associated liver disease and liver cancer.
    Hepatology. 2026;83:639-660.
    

    >> Share

    
    
16. QI X, Li J, Caussy C, Teng GJ, et al
    Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease.
    Hepatology. 2026;83:661-678.
    

    >> Share

    
    
17. GOLDBERG D, Blandon C, Delgado C, John B, et al
    Simulating the impact of survival benefit-based liver transplant organ allocation.
    Hepatology. 2025 Apr 4. doi: 10.1097/HEP.0000000000001338.
    

    >> Share

    
    
18. SCHWIMMER JB, Thai NQN, Noon SL, Ugalde-Nicalo P, et al
    Long-term mortality and extrahepatic outcomes in 1096 children with MASLD: A retrospective cohort study.
    Hepatology. 2026;83:561-574.
    

    >> Share

    
    
19. PIROLA CJ, Diambra L, Fernandez Gianotti T, Castano GO, et al
    Organ damage proteomic signature identifies patients with MASLD at risk of systemic complications.
    Hepatology. 2026;83:623-638.
    

    >> Share

    
    
20. VAN KLEEF LA, Pustjens J, Schattenberg JM, Holleboom AG, et al
    Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease in a general population with metabolic dysfunction.
    Hepatology. 2026;83:591-602.
    

    >> Share

    
    
21. ZHANG D, Abulitipu A, Pang P, Bai L, et al
    ECM1 protects against liver steatosis through PCBP1-mediated iron homeostasis.
    Hepatology. 2026;83:603-622.
    

    >> Share

    
    

    
    Int J Cancer

22. SCOTT KJ, West EJ, Brownlie RJ, Ismail F, et al
    Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma.
    Int J Cancer. 2026 Feb 16. doi: 10.1002/ijc.70386.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

23. JIANG E, Chen Y, Chen M, Zhou Y, et al
    Oncogenic LPCAT1 Accelerates Intrahepatic Cholangiocarcinoma Development Through PI3K/Akt Signaling-Dependent Cell Cycle Regulation.
    J Gastroenterol Hepatol. 2026 Feb 19. doi: 10.1111/jgh.70291.
    

    >> Share

    
    

    
    J Hepatol

24. SU JY, Lin LP, Huang ZH, Pan LX, et al
    Adjuvant Immunotherapy for Hepatocellular Carcinoma: Precision Selection of the Optimal Beneficiary Population as the Core Strategy.
    J Hepatol. 2026 Feb 15:S0168-8278(26)00075-9. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    
25. CAI J, Yip TC, Wong GL, Zhang Y, et al
    Global epidemiology of bacterial infections in patients with cirrhosis: a systematic review and meta-analysis.
    J Hepatol. 2026 Feb 16:S0168-8278(26)00071-1. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    
26. TELLEZ L, Donate J, Albillos A
    Early portopulmonary hypertension: a signal of increased mortality risk in cirrhosis.
    J Hepatol. 2026 Feb 17:S0168-8278(26)00074-7. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    
27. XU C, Sun J, Liang Q, Zhao H, et al
    Conversion surgery as a missing outcome in first-line immunotherapy trials for hepatocellular carcinoma: Conversion surgery in HCC immunotherapy.
    J Hepatol. 2026 Feb 18:S0168-8278(26)00025-5. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    
28. VILAR-GOMEZ E, Yates KP, Kleiner DE, Behling C, et al
    Genetic and non-genetic drivers of histological progression and regression in MASLD.
    J Hepatol. 2026;84:502-516.
    

    >> Share

    
    
29. EL-SERAG HB, Lopez C, Luster M, Reddy KR, et al
    HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort.
    J Hepatol. 2026;84:578-586.
    

    >> Share

    
    
30. ZHANG W, Xu Q, Xu K, Jiang R, et al
    Genetically engineered pig-to-human liver xenotransplantation.
    J Hepatol. 2026;84:587-598.
    

    >> Share

    
    
31. REIG M, Sanduzzi-Zamparelli M, Forner A, Rimola J, et al
    BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update.
    J Hepatol. 2026;84:631-654.
    

    >> Share

    
    
32. JIA XZ, Zhuang TT, Yang RS, Gu YW, et al
    Setd4-expressing cells drive regenerative recovery in chronic liver injury.
    J Hepatol. 2026;84:554-566.
    

    >> Share

    
    

    
    N Engl J Med

33. MUMOLI N, Serio G
    Hepatic Angiosarcoma.
    N Engl J Med. 2026;394:e11.
    

    >> Share

    
    

    
    PLoS One

34. TANVIR L, Afzal K, Abbas A, Amjad A, et al
    Integrating phytochemical analysis and experimental validation of Ziziphus jujuba seed powder and oil to ameliorate CCl4-induced liver fibrosis in sprague dawley rats.
    PLoS One. 2026;21:e0343428.
    

    >> Share

    
    
35. CHEN Z, Fan Y, Luo Y, Ye X, et al
    Hepatic arterial infusion chemotherapy (HAlC) versus sorafenib for hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) B/C: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0342495.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

36. QIN XY, Xu Y, Mishra H, Shirakami Y, et al
    Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.
    Proc Natl Acad Sci U S A. 2026;123:e2521923123.
    

    >> Share

    
    
37. HANNA BS, Langston PK, Marin-Rodero M, Ramirez RN, et al
    Regulatory T cells safeguard liver health during metabolic-associated steatohepatitis.
    Proc Natl Acad Sci U S A. 2026;123:e2536314123.
    

    >> Share

    
    

    
    Transplantation

38. HILL A, Hu Y, Park Y, Lovasik B, et al
    Low Model for End-Stage Liver Disease Score Patients Experience Significant Survival Advantage With Liver Transplantation.
    Transplantation. 2026 Jan 5. doi: 10.1097/TP.0000000000005601.
    

    >> Share

    
    
39. DONNELLY C, Kim JI, Motter JD, Ishaque T, et al
    Temporal Changes in Access to Transplantation Among Pediatric Registrants.
    Transplantation. 2026;110:e637-e646.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share